arm_1
1 clinical trial
1 product
1 indication
Clinical trial
An Open-Label, Single-Arm Study of Autologous Anti-HER2 Chimeric Antigen Receptor Monocytes (CT-0525), in Participants With HER2 Over Expressing Solid TumorsStatus: Recruiting, Estimated PCD: 2025-03-31
Product
Olaparib plus BevacizumabIndication
Ovarian Cancer